AnalystsReni BenjaminReni Benjamin's Stock Forecasts
AnalystsReni Benjamin
Sectors:
Industries:
Analyst Ranking
Top 16%
#669 out of 4241 analysts
Average Return
+4.75%
Win Rate
48%42 out of 88
Risk vs Reward
Poor
Good
Reni Benjamin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Effector Therapeutics IncEFTR | +245.00% | $0.40 | $1.38 | 2023-01-09 - 2023-06-09 | Buy |
Effector Therapeutics IncEFTR | +160.38% | $0.53 | $1.38 | 2022-11-17 - 2023-06-09 | Buy |
Spark Therapeutics IncONCE | +145.65% | $45.41 | $111.55 | 2018-11-07 - 2019-11-07 | Strong Buy |
Juno Therapeutics IncJUNO | +98.49% | $43.81 | $86.96 | 2017-08-29 - 2018-03-05 | Buy |
Cti Biopharma CorpCTIC | +90.53% | $4.75 | $9.05 | 2023-03-07 - 2023-06-09 | Buy |
Reni Benjamin Analyst Color
Get additional color on Reni Benjamin's coverage of popular stocks
Reni Benjamin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lava Therapeutics NvLVTX | 2 | Buy | $6.00 | +139.04% | Reiterates | 2 days ago |
Iovance Biotherapeutics IncIOVA | 5 | Buy | $18.00 | +128.14% | Reiterates | 6 days ago |
Deciphera Pharmaceuticals IncDCPH | 5 | Buy | $23.00 | +64.05% | Reiterates | 6 days ago |
Allogene Therapeutics IncALLO | 5 | Buy | $15.00 | +165.96% | Reiterates | 6 days ago |
Blueprint Medicines CorpBPMC | 4 | Buy | $114.00 | +94.97% | Reiterates | 19 days ago |
Sutro Biopharma IncSTRO | 2 | Buy | $17.00 | +218.95% | Reiterates | 25 days ago |
Cue Biopharma IncCUE | 2 | Buy | $15.00 | +304.31% | Reiterates | a month ago |
Bioatla IncBCAB | 3 | Buy | $12.00 | +228.77% | Reiterates | a month ago |
Adicet Bio IncACET | 2 | Buy | $19.00 | +255.14% | Reiterates | a month ago |
Bicycle Therapeutics PLCBCYC | 7 | Buy | $46.00 | +77.26% | Reiterates | a month ago |
Incyte CorpINCY | 10 | Buy | $93.00 | +52.36% | Maintains | a month ago |
Kura Oncology IncKURA | 1 | Buy | $22.00 | +68.32% | Reiterates | 2 months ago |
Cti Biopharma CorpCTIC | 4 | Buy | $9.00 | -0.55% | Reiterates | 3 months ago |
Seagen IncSGEN | 5 | Buy | $168.00 | -14.55% | Maintains | 4 months ago |
Spectrum Pharmaceuticals IncSPPI | 3 | Buy | $4.00 | +292.16% | Reiterates | 4 months ago |
Effector Therapeutics IncEFTR | 5 | Buy | $1.00 | -27.54% | Maintains | 5 months ago |
Compugen LtdCGEN | 1 | Buy | $4.00 | +205.34% | Maintains | 10 months ago |
Inhibrx IncINBX | 3 | Buy | $40.00 | N/A | Maintains | a year ago |
Trillium Therapeutics IncTRIL | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aceragen IncACGN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $36.00 | N/A | Initiates Coverage On | 3 years ago |
Eterna Therapeutics IncERNA | 2 | Buy | $5.00 | N/A | Maintains | 4 years ago |
Macrogenics IncMGNX | 2 | Hold | N/A | N/A | Upgrades | 4 years ago |
Regenxbio IncRGNX | 2 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Leap Therapeutics IncLPTX | 2 | Buy | $8.00 | N/A | Maintains | 4 years ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $72.00 | N/A | Upgrades | 5 years ago |
Adverum Biotechnologies IncADVM | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Buy | $16.00 | N/A | Maintains | 5 years ago |
Adma Biologics IncADMA | 2 | Buy | $10.00 | N/A | Maintains | 5 years ago |
Tg Therapeutics IncTGTX | 1 | Buy | $12.00 | N/A | Downgrades | 5 years ago |
Urogen Pharma LtdURGN | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Audentes Therapeutics IncBOLD | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Juno Therapeutics IncJUNO | 2 | Buy | N/A | N/A | Upgrades | 6 years ago |
Bellicum Pharmaceuticals IncBLCM | 2 | Buy | $180.00 | N/A | Maintains | 6 years ago |
Organovo Holdings IncONVO | 1 | Buy | $100.00 | N/A | Initiates Coverage On | 6 years ago |
Invivo Therapeutics Holdings CorpNVIV | 1 | Strong Buy | $243,750.00 | N/A | Initiates Coverage On | 7 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.